Omnipod

Shares of Insulet Corporation (NASDAQ: PODD) responded positively to the company’s solid results and guidance. The current share price reflects optimism around a Medicare coverage decision and could decline if the decision does not come soon, BTIG’s Sean Lavin said in a report. He...

Shares of Insulet Corporation (NASDAQ: PODD) are down 22.7 percent in the past three months in the face of increasing competition and repeated attacks by SkyTides. Amid all the bad news for the insulin delivery device maker, at least one person believes the dip in share price is a buying...

SkyTides on Friday continued its assault Friday on Insulet Corporation (NASDAQ: PODD) by releasing yet another report containing allegations of deceptive behavior within the company. The new report focuses on information that Insulet’s president Shacey Petrovic supplied to shareholders....

Since a follow-up report from research house SkyTides was published Tuesday morning, shares of Insulet Corporation (NASDAQ: PODD) had fallen more than 2 percent over the course of Wednesday's session. The report alleged investors in the company were "being led to slaughter" as...

SkyTides has followed up on a report from November 15 that Insulet Corporation (NASDAQ: PODD) has covered up patient deaths related to its Omnipod insulin pump. The report contained what SkyTides believes were 44 undisclosed Omnipod patient deaths and 51 FDA complaints that the product put...